In the study of Peng et al., the molecular analysis of CTLA-4 expression on different subtypes of breast cancer cells showed the highest CTLA-4 level in TNBC, which seems to be a direct confirmation of our results [33]. The gene discussed is CTLA4; the disease is breast cancer.